Unknown

Dataset Information

0

Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.


ABSTRACT: Although treatment with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) is known to protect a subset of cells from induction of apoptosis by death ligands such as Fas ligand and tumor necrosis factor-alpha-related apoptosis-inducing ligand, the mechanism of this protection is unknown. This study demonstrated that protection in short term apoptosis assays and long term proliferation assays was maximal when Jurkat or HL-60 human leukemia cells were treated with 2-5 nm PMA. Immunoblotting demonstrated that multiple PKC isoforms, including PKCalpha, PKCbeta, PKCepsilon, and PKC, translocated from the cytosol to a membrane-bound fraction at these PMA concentrations. When the ability of short hairpin RNA (shRNA) constructs that specifically down-regulated each of these isoforms was examined, PKCbeta shRNA uniquely reversed PMA-induced protection against cell death. The PKCbeta-selective small molecule inhibitor enzastaurin had a similar effect. Although mass spectrometry suggested that Fas is phosphorylated on a number of serines and threonines, mutation of these sites individually or collectively had no effect on Fas-mediated death signaling or PMA protection. Further experiments demonstrated that PMA diminished ligand-induced cell surface accumulation of Fas and DR5, and PKCbeta shRNA or enzastaurin reversed this effect. Moreover, enzastaurin sensitized a variety of human tumor cell lines and clinical acute myelogenous leukemia isolates, which express abundant PKCbeta, to tumor necrosis factor-alpha related apoptosis-inducing ligand-induced death in the absence of PMA. Collectively, these results identify a specific PKC isoform that modulates death receptor-mediated cytotoxicity as well as a small molecule inhibitor that mitigates the inhibitory effects of PKC activation on ligand-induced death receptor trafficking and cell death.

SUBMITTER: Meng XW 

PROVIDER: S-EPMC2801290 | biostudies-literature | 2010 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.

Meng Xue Wei XW   Heldebrant Michael P MP   Flatten Karen S KS   Loegering David A DA   Dai Haiming H   Schneider Paula A PA   Gomez Timothy S TS   Peterson Kevin L KL   Trushin Sergey A SA   Hess Allan D AD   Smith B Douglas BD   Karp Judith E JE   Billadeau Daniel D DD   Kaufmann Scott H SH  

The Journal of biological chemistry 20091103 2


Although treatment with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) is known to protect a subset of cells from induction of apoptosis by death ligands such as Fas ligand and tumor necrosis factor-alpha-related apoptosis-inducing ligand, the mechanism of this protection is unknown. This study demonstrated that protection in short term apoptosis assays and long term proliferation assays was maximal when Jurkat or HL-60 human leukemia cells were treated with 2-5 nm PM  ...[more]

Similar Datasets

| S-EPMC8469114 | biostudies-literature
| S-SCDT-10_15252-EMBJ_2023115030 | biostudies-other
| S-EPMC5058683 | biostudies-literature
| S-EPMC6548593 | biostudies-literature
| S-EPMC4426393 | biostudies-literature
| S-EPMC3807649 | biostudies-literature
| S-EPMC5056446 | biostudies-literature
2022-05-30 | GSE180635 | GEO
| S-EPMC4414154 | biostudies-literature
| S-EPMC3462190 | biostudies-literature